Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 13th November 2020
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Issues reported with supply of lactating cow intramammary antibiotics
Ubro Yellow Milking Cow Intramammary Suspension is one of the products to be suspended.

VMD updates list of available products

The Veterinary Medicines Directorate (VMD) has reported supply problems with certain lactating cow intramammary antibiotics.

The following is a list of lactating cow intramammary antibiotics that Marketing Authorisation Holders (MAHs) have noted availability problems for, along with anticipated resolution dates for each product:

Product Anticipated resolution date
Synulox Lactating Cow Intramammary Suspension (42058/4143) First quarter of 2021
Tetra-Delta Intramammary Suspension (42058/4152) First half of 2021
Ubro Yellow Milking Cow Intramammary Suspension (08327/4305) Product discontinued – no return date
Multiject IMM Intramammary Suspension (02000/4062) February 2021
Albiotic 330mg/100mg Intramammary Solution (30282/4035) December 2020
Mastiplan LC, 300mg/20mg Intramammary Suspension (01708/4534) End of November 2020
Cobactan MC Intramammary Suspension for Lactating Cows (01708/4444)* December 2020
Combiclav Intramammary Suspension for Lactating Cows (02000/4424) January 2021
Cefimam LC, 75 mg Intramammary Ointment for Lactating Cows (02000/4387)* product discontinued – no return date

These lactating cow intramammary products have been reported as available for veterinary surgeons to purchase:

Ubropen 600 mg Intramammary Suspension for Lactating Cows (42810/4000)
Ubrolexin Intramammary Suspension for Lactating Dairy Cows (08327/4306)
Procapen Injector 3g intramammary suspension for cattle (24745/4023)
Orbenin L.A. 200mg Intramammary Suspension (42058/4090)
Pathocef 250mg Intramammary Suspension (42058/4094)*

Please note: VMD states that the products marked with a '*' are defined as a Highest Priority Critically Important Antibiotics for human medicine and, under the Red Tractor farm assurance scheme for beef and dairy, should be used as a last resort and supported by sensitivity and/or diagnostic testing.

For further details of the supply situation for individual UK-authorised products, please contact the MAH or a wholesale dealer.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.